Silvec Biologics
Startup
Summarized by Halo AI
Silvec Biologics is a biotechnology company developing proprietary RNA therapies to immunize trees, vines, and bushes against viruses, bacteria, and fungi without genetic modification, aiming to replace traditional pesticides and GMO approaches.
Founded & HQ
Gaithersburg, MD, USA
Company size
1-10 employees
Funding
~$7M
IP status
5 patents filed · 2 grants confirmed
Activity highlights
Received a $250,000 follow-on Inclusion Fund investment from TEDCO to advance plant immunization technology development
Silvec Biologics is a biotech company specializing in RNA-based solutions for plant health, with a focus on protecting trees and perennial crops from pathogens.
AI summary generated on Jun 22, 2026
OpenAlex
OpenAlexFor general inquiries
RS
Rafael Simon
CEO
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.